CClinicalTrials.gg
Sign In
CompletedNCT00732589SSNBUpdated Nov 18, 2009

SSNB in Hemiplegic Shoulder Pain

A Phase 2 interventional study of 1% xylocaine and ultrasound in Shoulder Pain and Stroke, sponsored by Chulalongkorn University. Completed at 1 site in Thailand. Open to female participants. Per ClinicalTrials.gov, last updated 2009-11-18.

Sponsored by Chulalongkorn University · Phase 2, Interventional, and Treatment

Phase
Phase 2
Study type
Interventional
Enrollment
0
Allocation
Randomized
Sex
Female
01

Study summary

The purpose of this study is to compare suprascapular nerve block with therapeutic ultrasound in stroke patients who have shoulder pain in weak side.

Read the detailed description

Shoulder pain is a common complication after a cerebrovascular accident.Hemiplegic shoulder pain has been shown to affect stroke outcome in a negative way.It interferes with recovery after stroke:it can cause distress and reduced activities and can markedly hinder rehabilitation.Suprascapular nerve block has been shown to be effective as an analgesic for different indications such as shoulder capsulitis.The purpose of this study was to evaluate the effectiveness of this technique conjunction with a rehabilitation program to reduce shoulder pain in hemiplegic patients.

02

Conditions studied

  • Shoulder Pain
  • Stroke

Browse trials for

Keywords

  • suprascapular nerve block
  • shoulder pain
  • hemiplegia
03

In context

Shoulder Pain

707 studies on the registry are indexed under Shoulder Pain; 152 are open to participants now.

Browse Shoulder Pain studies →

Lead sponsor

Chulalongkorn University is the lead sponsor of 312 studies on the registry; 59 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Stroke patients who develope shoulder pain at weak limb.
  • Good conscious and able to access pain score.
  • No history of drug reaction with xylocaine
  • No history of fracture,tumor or blood tendency.
  • Willing to enrolled to study and signs inform consent.

Exclusion criteria

Exclusion Criteria:

  • Patients who do not meet the inclusion criteria.
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
0 participants (estimated)

Study arms

  • Experimental
    A

    Suprascapular nerve block

    Drug: 1% xylocaine

  • Experimental
    B

    therapeutic ultrasound

    Other: ultrasound

Interventions

  • Drug1% xylocaine

    10 cc. of 1%xylocaine, once a week

    Also known as: suprascapular nerve block

  • Otherultrasound

    ultrasound at shoulder area about 10 mins.

    Also known as: therapeutic ultrasound

06

What researchers measure

Primary outcomes

  1. VAS score of pain

    Time frame: 4 weeks after intervention

Secondary outcomes

  1. Range of motion of the shoulder joint

    Time frame: 4 weeks after intervention

07

Study locations

1 site
  • Department of physical medicine and rehabilitation, Faculty of medicien, Chulalongkorn University
    Bangkok, Thailand
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 18, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00732589
Lead sponsor
Chulalongkorn University
First posted
Aug 12, 2008
Start date
Aug 2008
Primary completion
Dec 2008
Completion
May 2009
Last update
Nov 18, 2009

Study contacts

Jariya Boonhong, physiatist
principal investigator · Unaffiliation

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Shoulder Pain→

Other studies from this sponsor

Chulalongkorn University

Start the discussion